© 2003 by Oxford University Press
Journal of the National Cancer Institute, Vol. 95, No. 14, 1087,
July 16, 2003
© 2003 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Insulin Resistance and Prostate Cancer Risk
Affiliations of authors: A. Hsing, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; S. Chua Jr., Division of Molecular Genetics, Department of Pediatrics, Columbia University, New York, NY.
Correspondence to: Ann Hsing, Ph.D., National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics, EPS-7058, MSC-7234, 6120 Executive Blvd., Bethesda, MD 20852-7234 (e-mail: hsinga@mail.nih.gov).
| The first 10% of the full text of this article appears below. |
We agree with Drs. Stattin and Kaaks that our earlier findings associating abdominal obesity, hyperinsulinemia, and insulin resistance with prostate cancer risk in Chinese men with a relatively low body mass index (BMI; average BMI = 21 kg/m2) cannot be readily extrapolated to Western men and that these associations need to be replicated in prospective studies and other populations.